Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 8.97
-1.18 (-11.63%)
Aug 21, 2026, 3:05 PM CST
SHE:300009 Market Cap
SHE:300009 has a market cap or net worth of 14.95 billion as of August 21, 2026. Its market cap has decreased by -23.65% in one year.
Market Cap
14.95B
Enterprise Value
13.49B
Revenue
2.56B
Ranking
n/a
PE Ratio
21.39
Stock Price
8.97
ChartMarket Cap Chart
Since October 30, 2009, SHE:300009's market cap has increased from 4.21B to 14.95B, an increase of 255.48%. That is a compound annual growth rate of 7.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 14.95B | -6.34% |
| Dec 31, 2025 | 15.97B | 10.76% |
| Dec 31, 2024 | 14.41B | -15.68% |
| Dec 29, 2023 | 17.09B | 9.42% |
| Dec 30, 2022 | 15.62B | -27.16% |
| Dec 31, 2021 | 21.45B | 7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightGene Bio-Medical Technology | 16.82B |
| Acrobiosystems | 15.29B |
| HitGen | 15.09B |
| Sino Biological,Inc. | 14.76B |
| GemPharmatech | 14.72B |
| Jinyu Bio-technology | 14.31B |
| Shanghai Medicilon | 14.27B |
| Mabwell (Shanghai) Bioscience | 14.11B |